This real‐world study aims to describe the proportion of patients with a symptomatic hypoglycaemic event and the proportion of individuals with type 2 diabetes, who newly or recently initiated with basal insulin, achieving individual o general HbA1c target in Argentina. This evidence concerns the gene INS and type 2 diabetes mellitus.